Male Breast Cancer Recruiting Phase 0 Trials for Propranolol (DB00571)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02013492Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryTreatment